AAP
TRDA icon

Arax Advisory Partners’s Entrada Therapeutics TRDA Stock Holding History

Arax Advisory Partners’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.6K Buy
919
+1
+0.1% +$11 ﹤0.01% 2363
2025
Q4 		$9.44K Sell
918
-361
-28% -$3.04K ﹤0.01% 2499
2025
Q3 		$7.42K Buy
1,279
+814
+175% +$4.76K ﹤0.01% 2725
2025
Q2 		$3.13K Buy
+465
New +$3.74K ﹤0.01% 2414
2024
Q4 		– Sell
-45
Closed -$720 – 2748
2024
Q3 		$720 Hold
45
– – ﹤0.01% 2337
2024
Q2 		$642 Buy
+45
New +$640 ﹤0.01% 2287

Other funds holding TRDA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return